Celularity (CELU) Revenue (2020 - 2026)
Celularity's Revenue was $4.1 million in Q4 2025, down 77.4% from $18.13 million a year earlier and down 22.3% from the prior quarter.
Powered by 
Analysis
Celularity (CELU) Revenue (2020 - 2026) Analysis & Trends
For FY2025, Revenue at Celularity came in at $26.55 million, down 51.0% from FY2024.
- Revenue shows a five-year compound annual growth rate of 13.2% (FY2020 to FY2025).
- In earlier years, Revenue was $54.22 million in FY2024 (+138.1%), $22.77 million in FY2023 (+26.7%), $17.98 million in FY2022 (-15.7%) and $21.34 million in FY2021 (+49.4%).
- The Q4 2025 figure marks the lowest quarterly Revenue since Q3 2023.
- Compared with a year earlier, Revenue has declined for four straight quarters, with growth averaging 73.2% over the last eight quarters.
- The best year-over-year quarter for Revenue over five years was Q2 2024 (growth of 312.2%); the worst was Q4 2025 (a decline of 77.4%).
- Per Business Quant data, CELU's Revenue in the three quarters before Q4 2025 was $5.28 million (Q3 2025), $5.74 million (Q2 2025) and $11.43 million (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.31 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 16.99 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 16.61 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 14.41 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 15.38 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 10.05 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 7.80 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 15.03 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 3.33 Bn |
| 10 | Celularity | 39.39 Mn | 31.87 Mn | 2.39 Mn | 3.85 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 3.85 Mn |
| Dec 31, 2025 | 4.10 Mn |
| Sep 30, 2025 | 5.28 Mn |
| Jun 30, 2025 | 5.74 Mn |
| Mar 31, 2025 | 11.43 Mn |
| Dec 31, 2024 | 18.13 Mn |
| Sep 30, 2024 | 9.30 Mn |
| Jun 30, 2024 | 12.11 Mn |
| Mar 31, 2024 | 14.68 Mn |
| Dec 31, 2023 | 12.11 Mn |
| Sep 30, 2023 | 3.79 Mn |
| Jun 30, 2023 | 2.94 Mn |
| Mar 31, 2023 | 3.94 Mn |
| Dec 31, 2022 | 4.13 Mn |
| Sep 30, 2022 | 4.14 Mn |
| Jun 30, 2022 | 3.78 Mn |
| Mar 31, 2022 | 5.94 Mn |
| Dec 31, 2021 | 4.86 Mn |
| Sep 30, 2021 | 10.62 Mn |
| Jun 30, 2021 | 3.20 Mn |
API Access
Celularity Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=CELU&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "CELU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=CELU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();